Earnings History Data for Opiant Pharmaceuticals, Inc. (OPNT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-08-2022	AH	4:05 PM ET (Aug 11)	OPNT	Opiant Pharmaceuticals, Inc.	51.38	-2.31	-1.29	0.31	Opiant Pharmaceuticals GAAP EPS of -$2.31 misses by $0.95, revenue of $3.89M misses by $0.77M [8/11/2022 4:39 PM]	12.86	0.28 (2.23%)	0.0	0.0 (0.00%)	7.34 - 37.71	31,395	20,000	0
Opiant Pharmaceuticals GAAP EPS of -$2.31 misses by $0.95, revenue of $3.89M misses by $0.77M [8/11/2022 4:39 PM] Opiant Pharmaceuticals Announces Second Quarter and First Half 2022 Financial Results and Provides Corporate Update [Aug-11-22 04:05PM]
10-05-2022	AH	4:05 PM ET (May 10)	OPNT	Opiant Pharmaceuticals, Inc.	97.43	-2.43	-0.75	-0.66	Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43M [5/10/2022 4:09 PM]	11.95	-6.40 (-34.88%)	0.0	0.0 (0.00%)	11.08 - 37.71	548,994	220,000	0
Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43M [5/10/2022 4:09 PM] Opiant Pharmaceuticals' (NASDAQ:OPNT) investors will be pleased with their solid 195% return over the last five years [May-09-22 10:54AM] Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update [May-10-22 04:01PM]
15-03-2022	AH	4:05 PM ET (Mar 15)	OPNT	Opiant Pharmaceuticals	120.00	0.11	0.10	0.00	Opiant Pharmaceuticals GAAP EPS of $0.11 beats by $0.01, revenue of $13.8M beats by $0.54M [3/15/2022 4:09 PM]	25.10	-0.10 (-0.38%)	25.00	-0.20 (-0.79%)	10.00 - 37.71	53,453	65,813	3,760
Opiant Pharmaceuticals Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update [Mar-15-22 04:05PM]
11-11-2021	AH	4:00 PM ET (Nov 11)	OPNT	Opiant Pharmaceuticals, Inc.	121.65	0.56	0.15	0.15	Opiant Pharmaceuticals EPS beats by $0.35, beats on revenue [11/11/2021 4:05 PM]	25.66	-2.76 (-9.71%)	29.27	0.85 (2.99%)	7.27 - 29.51	105,850	40,000	1,180
Opiant Pharmaceuticals EPS beats by $0.35, beats on revenue [11/11/2021 4:05 PM] Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference [Nov-10-21 04:05PM] Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-11-21 04:05PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	OPNT	Opiant Pharmaceuticals, Inc.	69.64	0.31	-0.34	-0.05	Opiant Pharmaceuticals EPS beats by $0.59, beats on revenue [8/5/2021 4:49 PM]	15.93	0.15 (0.93%)	15.80	0.02 (0.13%)	6.79 - 19.90	40,823	40,000	379
10 Pharma Companies Making Treatment for Opioid Overdose [Aug-04-21 09:34AM] Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-05-21 04:01PM] OPNT: PD Data for OPNT003 Expected 4Q21 [Aug-06-21 07:39AM]
11-05-2021	AH	4:05 PM ET (May 11)	OPNT	Opiant Pharmaceuticals, Inc.	54.13	-0.66	-0.71	-0.40	Opiant Pharmaceuticals EPS beats by $0.09, beats on revenue [5/11/2021 4:15 PM]	12.50	-0.40 (-3.10%)	0.0	0.0 (0.00%)	6.79 - 14.98	11,754	20,000	0
Opiant Pharmaceuticals EPS beats by $0.09, beats on revenue [5/11/2021 4:15 PM] Opiant Pharmaceuticals, Inc. to Host Earnings Call [May-11-21 02:30PM] Opiant Pharmaceuticals Announces First Quarter 2021 Financial Results and Corporate Update [May-11-21 04:05PM]
04-03-2021	AH	4:05 PM ET (Mar 4)	OPNT	Opiant Pharmaceuticals, Inc.	56.16	-0.16	0.12	0.20	Opiant Pharmaceuticals EPS misses by $0.23, beats on revenue [3/4/2021 4:43 PM]	12.42	-0.87 (-6.55%)	14.00	0.71 (5.34%)	6.79 - 14.98	77,124	29,776	511
Opiant Pharmaceuticals EPS misses by $0.23, beats on revenue [3/4/2021 4:43 PM]
12-11-2020	AH	4:05 PM ET (Nov 12)	OPNT	Opiant Pharmaceuticals, Inc.	30.83	0.15	-0.19	0.00	Opiant Pharmaceuticals EPS beats by $0.36, beats on revenue [11/12/2020 4:16 PM]	7.71	0.41 (5.62%)	7.98	0.68 (9.32%)	6.79 - 18.23	35,253	15,592	594

06-08-2020	AH	4:05 PM ET (Aug 6)	OPNT	Opiant Pharmaceuticals, Inc.	38.96	-0.05	-0.31	0.31	Opiant Pharmaceuticals EPS beats by $0.19, beats on revenue [8/6/2020 4:17 PM]	9.09	-0.05 (-0.55%)	9.32	0.18 (1.97%)	8.05 - 18.23	22,147	23,928	1,301

12-05-2020	AH	4:05 PM ET (May 12)	OPNT	Opiant Pharmaceuticals, Inc.	50.18	-0.40	-0.31	-0.44	Opiant Pharmaceuticals EPS misses by $0.21, misses on revenue [5/12/2020 4:07 PM]	10.86	-0.89 (-7.57%)	10.82	10.82 (0.00%)	8.05 - 18.23	46,498	23,230	804